Abstract:Genomic copy number alteration and allelic imbalance are distinct features of cancer cells, and recent advances in the genotyping technology have greatly boosted the research in the cancer genome. However, the complicated nature of tumor usually hampers the dissection of the SNP arrays. In this study, we describe a bioinformatic tool, named GIANT, for genome-wide identification of somatic aberrations from paired normal-tumor samples measured with SNP arrays. By efficiently incorporating genotype information of matched normal sample, it accurately detects different types of aberrations in cancer genome, even for aneuploid tumor samples with severe normal cell contamination. Furthermore, it allows for discovery of recurrent aberrations with critical biological properties in tumorigenesis by using statistical significance test. We demonstrate the superior performance of the proposed method on various datasets including tumor replicate pairs, simulated SNP arrays and dilution series of normal-cancer cell lines. Results show that GIANT has the potential to detect the genomic aberration even when the cancer cell proportion is as low as 5∼10%. Application on a large number of paired tumor samples delivers a genome-wide profile of the statistical significance of the various aberrations, including amplification, deletion and LOH. We believe that GIANT represents a powerful bioinformatic tool for interpreting the complex genomic aberration, and thus assisting both academic study and the clinical treatment of cancer.

Statistical Methods For The Analysis Of Next Generation Sequencing Data From Paired Tumor-Normal Samples

Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples

Analysis of cancer genome alterations using single nucleotide polymorphism (SNP) microarrays

A novel framework for analyzing somatic copy number aberrations and tumor subclones for paired heterogeneous tumor samples

Analytical Methods for Inferring Functional Effects of Single Base Pair Substitutions in Human Cancers

Comprehensive Assessment of Somatic Copy Number Variation Calling Using Next-Generation Sequencing Data

Next Generation Sequencing Technology in the Clinic and Its Challenges

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

A Novel CNA/LOH Detection Algorithm Using Normal-Tumor SNP-Array Data

[Common Cancer Genetic Analysis Methods and Application Study Based on TCGA Database].

SCONCE: a method for profiling copy number alterations in cancer evolution using single-cell whole genome sequencing

Joint Detection of Germline and Somatic Copy Number Events in Matched Tumor-Normal Sample Pairs.

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization

Special section: Statistical methods for next-generation gene sequencing data

Integrated Modeling of GC-Content, Mappability, Tumor Impurity and Aneuploidy for Accurate Detection of Genomic Aberrations.

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

Statistical Methods for Detecting Genomic Alterations Through Array-Based Comparative Genomic Hybridization (CGH).

High resolution copy number inference in cancer using short-molecule nanopore sequencing

A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data